Pharmacist-integrated model of medication treatment for opioid use disorder. 12/01/2023 - 03/31/2025. N01DA-22-2253. Task order no. 75N95024F00001 (TO17).
Ended Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $374,923
Award facts
- Opportunity
-
- 75N95024F00001 Solicitation number
- Contract value 100% obligated
- $374,923.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Original award | $374,923 |
About this award
This is a Cost Plus Fixed Fee delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to The Emmes Company LLC, a for-profit limited liability company based in Rockville, Maryland. The contract is for a project titled "PHARMACIST-INTEGRATED MODEL OF MEDICATION TREATMENT FOR OPIOID USE DISORDER" with a period of performance from December 1, 2023 to March 31, 2025. The contract has a ceiling value of $374,923.00 and is not set aside. The Emmes Company LLC is a global clinical research organization that provides comprehensive research support services to federal agencies, particularly within the NIH. This delivery order is issued under the NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER program, which is an Indefinite Delivery Vehicle (IDV) contract that allows Emmes to provide rapid, flexible support across multiple research domains related to substance abuse and addiction.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on December 1, 2023.
How much is contract 75N95024F00001 worth?
The government has obligated $374,923 on 75N95024F00001.
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award